Research map: A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T‐Cell Lymphoma

Back to the article

Papers in this map

  1. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee · Elı́as Campo · 2022 · 1607 citations · Cited by this paper
  2. Low‐Dose Chidamide Maintenance Therapy After Hematopoietic Stem Cell Transplantation for T‐Cell Acute Lymphoblastic Leukemia: A Case Series · 2026 · Related
  3. Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy · Bertrand Coiffier · 2012 · 684 citations · Cited by this paper
  4. Decoding the Heterogeneity of Diffuse Large B‐Cell Lymphomas: A Comprehensive Genetic, Transcriptomic, and Phenotypic Profiling of B‐Cell Lymphoma Cell Lines · 2026 · Related
  5. Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study · Owen A. O’Connor · 2011 · 652 citations · Cited by this paper
  6. Sequential BV‐AVD Therapy in Richter Transformation: Insights Into the Management of Elderly Patients · 2026 · Related
  7. Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study · Owen A. O’Connor · 2015 · 560 citations · Cited by this paper
  8. Nucleoporin 98 Rearrangements in Acute Leukemia: A Genomic Landscape Study · 2026 · Related
  9. The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer · Jennifer Marie Spangle · 2017 · 176 citations · Cited by this paper
  10. Trends in Incidence and Survival of Patients With Primary Effusion Lymphoma in the United States: A Population Based Cohort Study · 2026 · Related
  11. The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project · Monica Bellei · 2018 · 162 citations · Cited by this paper
  12. Real‐World Treatment Patterns and Healthcare Resource Utilization of Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma in the United States · 2026 · Related
  13. Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study · Owen A. O’Connor · 2019 · 130 citations · Cited by this paper
  14. Integrative Transcriptomic and Functional Analysis of PKMYT1 Reveals a Potential Therapeutic Target in Chronic Lymphocytic Leukemia · 2026 · Related
  15. Managing toxicities of phosphatidylinositol-3-kinase (PI3K) inhibitors · Ashley Hanlon · 2020 · 90 citations · Cited by this paper
  16. Matching‐Adjusted Indirect Comparison of Gecacitinib, Fedratinib, Pacritinib, and Momelotinib in Second‐Line Myelofibrosis Therapy · 2026 · Related
  17. Duvelisib, an oral dual PI3K‐δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study · Susan Mary O'Brien · 2018 · 60 citations · Cited by this paper
  18. Clinical Significance of FLT3‐ITD Variation Allele Frequency in Acute Myeloid Leukemia: A Multicenter Study · 2026 · Related
  19. Response to 5‐azacytidine in a patient with TET2‐mutated angioimmunoblastic T‐cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV‐positive large B‐cell lymphoma · Colombe Saillard · 2016 · 47 citations · Cited by this paper
  20. Sustained Complete Response in Refractory Idiopathic Multicentric Castleman Disease Following a Single CD19 CAR T‐Cell Infusion: A Case Report With Mechanistic Insight · 2026 · Related
  21. Inhibition of DNA methyltransferase as a novel therapeutic strategy to overcome acquired resistance to dual PI3K/mTOR inhibitors · Xiao-Jun Qian · 2015 · 33 citations · Cited by this paper
  22. Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis · Paolo Fagone · 2018 · 25 citations · Cited by this paper
  23. Brentuximab vedotin in Hodgkin's lymphoma · Barbara Pro · 2012 · 20 citations · Cited by this paper
  24. Update on T-cell lymphoma · Julie Marie Vose · 2008 · 13 citations · Cited by this paper
  25. Influence of demethylation on regulatory T and Th17�cells in myelodysplastic syndrome · Xinyan Jia · 2019 · 11 citations · Cited by this paper

Source: OpenAlex (CC0)